"FDA Approves Dexcom Stelo, First Over-the-Counter Continuous Glucose Monitor for Non-Insulin Users Over 18, Enhancing Health Equity Nationwide

"FDA Approves Dexcom Stelo, First Over-the-Counter Continuous Glucose Monitor for Non-Insulin Users Over 18, Enhancing Health Equity Nationwide - March 5, 2024"

FDA Clears First Over-the-Counter Continuous Glucose Monitor

For Immediate Release: March 05, 2024 Today, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin, such as individuals with diabetes treating their condition with oral medications, or those without diabetes who want to better understand how diet and exercise may impact blood sugar levels. Im...